Tinospora india

Condiciones de salud que Tinospora india puede ayudar a apoyar.

• Abuso y TraumaCientífico

  A randomized double-blind placebo-controlled trial (n=75, 8 weeks) found Tinospora cordifolia extract produced significant relief from sneezing, nasal discharge, nasal obstruction, and nasal pruritus in allergic rhinitis patients compared to placebo. A specific extract (Tinofend) has been identified as the studied formulation. Evidence is promising but limited to a single small trial whose dramatic effect sizes have drawn some methodological scrutiny.

• HipocondríaCientífico

  T. cordifolia exhibits well-characterized antioxidant activity in vitro and in vivo. Its phytoconstituents—polyphenols, alkaloids, diterpenoids, flavonoids—inhibit lipid peroxidation, scavenge free radicals, and upregulate endogenous antioxidant enzymes. This antioxidant activity underpins many of its other biological effects (hepatoprotective, neuroprotective, anti-inflammatory). Both in vitro and animal data are extensive; clinical human antioxidant endpoint studies are limited.

• HipotensiónCientífico

  A human clinical trial (PMC4895752) in healthy volunteers found T. cordifolia at 150–300 mg/day for 28 days significantly reduced exercise-induced systolic and diastolic blood pressure versus placebo. The proposed mechanism is suppression of sympathetic nervous system overactivation. This is the primary human clinical evidence; additional large-scale trials are needed.

• Fatiga SuprarrenalCientífico

  Multiple preclinical and some clinical studies support antidiabetic activity. Clinical trials in type 2 diabetics report reduced fasting blood glucose with T. cordifolia extract. The alkaloid berberine and the diterpenoid tinosporaside have been shown to augment GLUT4 translocation and activate AMPK in skeletal muscle, providing a mechanistic basis. WebMD/RxList summarize that taking it 'by mouth seems to improve blood sugar in adults with type 2 diabetes.'

• Válvula IleocecalCientífico

  Preclinical studies and at least one small human clinical study support lipid-lowering effects. A pilot clinical study (n=24) in hypertriglyceridemic patients found T. cordifolia extract (3 g/day, 14 days) produced improvements in triglycerides, total cholesterol, and LDL comparable to metformin. In vitro and animal data additionally show reduction of serum and tissue cholesterol, phospholipids, and free fatty acids.

• ApendicitisCientífico

  T. cordifolia has been traditionally used for chronic inflammatory conditions, and preclinical evidence is substantial. A PMC-indexed study demonstrated that chloroform extract inhibits LPS-induced NF-κB activation in THP-1 cells and suppresses TNF-α and other pro-inflammatory cytokines. Anti-inflammatory activity is attributed to alkaloids including berberine, which inhibits the TNF-α-triggered proinflammatory cascade and reduces iNOS-mediated nitrosative stress.

• Envenenamiento QuímicoCientífico

  T. cordifolia has well-established hepatoprotective activity in preclinical models (CCl4, lead, anti-tuberculosis drugs) and limited but positive clinical data. Its hepatoprotective effects are mediated through inhibition of lipid peroxidation, antioxidant enzyme induction, and alkaloid-driven anti-inflammatory pathways. A 2024 narrative review in the Journal of Pharmacy and Pharmacology concludes that T. cordifolia 'is an effective hepatoprotective agent against various hepatotoxic substances.'

• EscalofríosCientífico

  A 21-day randomized, double-blind, placebo-controlled trial (Bairy et al., 2004; n=30 healthy volunteers, 500 mg/day aqueous extract) found significant improvements in verbal learning, immediate logical memory, and short-term logical memory versus placebo. T. cordifolia is classified in Ayurveda as a Medhya Rasayana (intellect-promoting tonic). Animal studies additionally demonstrate protection against cyclosporine-induced hippocampal neurodegeneration.

• Tos (seca)Científico

  The clinical evidence base for seasonal allergies overlaps directly with the allergic rhinitis trial (Badar et al., 2005), which enrolled hay fever patients. T. cordifolia extract significantly reduced hallmark seasonal allergy symptoms including sneezing, nasal discharge, and itching versus placebo over 8 weeks. It is recognized by EBSCO Research Starters as showing anti-allergic benefits specifically for hay fever.

• Fibrosis QuísticaCientífico

  T. cordifolia is classified as an adaptogen (Rasayana) in Ayurveda, and a human clinical trial tested it under physical stress conditions. A PMC-indexed study (PMC4895752) in healthy adult volunteers found that T. cordifolia administration significantly decreased systolic and diastolic blood pressure and heart rate in response to exercise-induced physical stress versus placebo, indicating suppression of sympathetic overactivation.

• Sarpullido por pañalCientífico

  Indian tinospora (Tinospora cordifolia) is used in Ayurvedic medicine as a primary immunomodulatory herb for infectious diseases including viral conditions. Its polysaccharides and alkaloids enhance macrophage, NK cell, and T cell function. Clinical evidence supports reductions in dengue fever severity and adjunctive use in COVID-19.

• DifteriaCientífico

  A PLOS One (2025) in vivo mouse skin wound model study using direct T. cordifolia extraction demonstrated histopathologically confirmed accelerated wound healing—reduced inflammation, restored blood vessels, collagen fiber formation, and swift epidermal closure by day 10. Antibacterial and anti-inflammatory properties underpin the mechanism. Traditional use for wound healing is also well-documented.

• DislocaciónTradicional

  T. cordifolia is documented in traditional Ayurvedic use for digestive discomfort, dyspepsia, and stomach upset. It is described as stomachic and carminative in classical texts. RxList lists 'upset stomach' as a documented traditional use. No clinical trial with abdominal discomfort as a primary endpoint is available.

• DispepsiaTradicional

  Traditional Ayurvedic texts classify T. cordifolia as a 'blood purifier' (Raktashodhaka) used for anemia. A preclinical study (PubMed 31358831) showed T. cordifolia significantly raised hemoglobin and RBC count in inflammation-associated anemia in Wistar rats by modulating hepcidin expression and inflammatory cytokines. Human clinical data are not available.

• EccemaTradicional

  T. cordifolia has a long traditional history of use for joint pain and arthritis in Ayurveda, Siddha, and folk medicine across South and Southeast Asia. Preclinical data support anti-inflammatory and anti-arthritic activity. It is listed in ethnopharmacological compendiums as commonly used in combination with other herbs for gout and rheumatoid arthritis; controlled human trials for arthritis as a primary endpoint are not available.

• EdemaTradicional

  T. cordifolia is documented in Ayurvedic and ethnobotanical literature as a traditional treatment for asthma ('Shwasa roga'). Classical texts cite its use, and multiple ethnomedicinal surveys confirm it. Preclinical data suggest anti-inflammatory and bronchial smooth muscle-relaxing effects, but human clinical trials for asthma as a primary endpoint do not exist.

• Contaminación ElectromagnéticaTradicional

  Indian tinospora (Tinospora cordifolia) has deep traditional Ayurvedic use as an immunomodulator for rheumatic and inflammatory autoimmune conditions. It modulates macrophage, NK cell, and lymphocyte activity. Preclinical studies confirm anti-inflammatory and immunoregulatory effects; clinical RCT data in specific autoimmune diseases remain limited.

• Trastornos AutoinmunesTradicional

  T. cordifolia is consistently documented in Ayurvedic classical texts and ethnomedicinal surveys as a treatment for diarrhea and dysentery. It is listed as 'anti-diarrheal' in multiple pharmacological reviews. No controlled human clinical trial with diarrhea as a primary endpoint has been published.

• Sangrado (interno)Tradicional

  Antipyretic use is one of the oldest and most consistently documented traditional applications of T. cordifolia across Ayurveda, Siddha, and Unani systems. Ayurvedic texts describe it as 'Jwaranashana' (fever-alleviating). Preclinical studies have confirmed antipyretic activity, but controlled human trials specifically for fever are not available.

• Miedo (excesivo)Tradicional

  Gout is among the classical Ayurvedic indications for T. cordifolia ('Vatarakta'). Preclinical data suggest it inhibits enzymes related to uric acid production and reduces plasma uric acid levels in animal models. Traditional use for gout is documented across Ayurveda, Siddha, and folk systems. No controlled human trials for gout specifically are available.

• JuanetesTradicional

  T. cordifolia is classified as 'cardiovascular protective' in Ayurvedic tradition and multiple pharmacological reviews. Preclinical data demonstrate antiarrhythmic effects and lipid normalization. A human trial found it reduces exercise-induced blood pressure and heart rate. Traditional use for cardiac ailments is documented in classical texts.

• GingivitisTradicional

  T. cordifolia's traditional Ayurvedic designation as a drug that regulates metabolism (Deepana) and its documented activity on blood glucose, triglycerides, cholesterol, and inflammation places it within the metabolic syndrome spectrum. A clinical pilot trial in hypertriglyceridemic patients supports metabolic benefit. Comprehensive metabolic syndrome RCTs are not available.

• Cabello (pérdida o adelgazamiento)Tradicional

  T. cordifolia has traditional use for menstrual and hormonal conditions in Ayurveda. Preclinical animal model evidence (letrozole-induced PCOS in mice) shows TC oil preparation reversed PCOS-related morphological and metabolic effects. A PMC review (PMC10221073) identifies TC's role in managing insulin resistance and lipid/carbohydrate metabolism associated with PCOS. No human clinical trials for PCOS are available.

• Dolor de cabeza (tensión)Tradicional

  Rheumatoid arthritis is listed as a traditional indication in Ayurveda and is referenced in RxList, RxList, and the genus Tinospora ethnopharmacology review. Preclinical anti-inflammatory mechanisms (NF-κB inhibition, cytokine suppression) are pharmacologically consistent with RA pathophysiology. No standalone RCT in RA patients has been published.

• Hernia HiatalTradicional

  T. cordifolia root extract has anti-ulcer activity noted in traditional use and some preclinical models. RxList identifies peptic ulcer disease as a documented traditional use. Preclinical studies with polyherbal formulations containing T. cordifolia have shown anti-ulcer and antioxidant activity. The root specifically is noted to possess anti-ulcer activity in traditional Ayurvedic texts.

Sistemas corporales que Tinospora india puede ayudar a apoyar.

• No hay sistemas corporales disponibles.